MedWatch

Leo Pharma's team in Boston: "We send 5-10 possibilities back to Denmark each month"

Leo Science & Tech Hub in the biotech city Boston has already initiated a number of collaborations of new technologies in the field of dematology. This summer, it will send its first two validated projects back the the headquarters in Denmark, says Michael Sierra, Head of the US office.

Michael Sierra, VP, Leo Science & Tech Hub. Photo: Leo Pharma/PR

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Her er de vigtigste nyheder fra MedWatch i uge 38

En "digital transformation" i Novo Nordisks F&U-afdeling, som koster 400 medarbejdere jobbet, stjal fokus i uge 38, hvor Zealand Pharma ramte plet i et afgørende fase 3-studie og Coloplast holdt kapitalmarkedsdag. MedWatch giver dig her overblikket over ugens vigtigste begivenheder.

CHMP får ny, tysk formand

Ved sit septembermøde har EU's ekspertkomité på ibrugtagning af nye lægemidler, CHMP, valgt en ny formand for de næste tre år, ny næstformand skal vælges i næste måned.

Related articles